
|Videos|March 29, 2016
Advantages of Novel Oral Anticoagulants Over Vitamin K Antagonists
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























